ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Early- versus late-onset mortality trends in breast and female genital cancers in Spain, 1999-2024.
Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast and gynaecological cancers represent the leading oncological burden among women worldwide. We aimed to describe long-term mortality trends for these malignancies in Spain over a 26 year period, focusing on differences between early-onset (< 50 years) and late-onset (≥ 50 years) disease.
methodsMortality data (1999-2024) were obtained from the Spanish National Institute of Statistics. Age-standardised mortality rates (ASMRs) were calculated per 100,000 women using the 2013 European Standard Population. Joinpoint regression estimated annual percentage changes (APC) and average annual percentage changes (AAPC) with 95% confidence intervals (CI).
resultsTotal annual deaths rose from 9531 to 11,641, despite declining ASMRs for most sites. Breast cancer mortality decreased consistently (AAPC - 1.4%; 95% CI - 1.5, - 1.3), with a more pronounced reduction in the < 50 group (AAPC - 2.5%). Significant ASMR declines were observed for uterus NOS (- 2.3%), ovary (- 0.7%), and cervix uteri (- 0.6%). In the < 50 cohort, ovarian cancer mortality fell sharply (AAPC - 2.1%). Conversely, corpus uteri cancer was the only site showing an increasing trend (AAPC + 0.4%; 95% CI 0.1, 0.8), with a steeper increase observed among women ≥ 50 years. Non-monotonic trends were identified for less common gynaecological cancers.
conclusionsMortality rates for breast and most gynaecological cancers in Spain have declined, although absolute deaths have increased. These trends are potentially consistent with advances in prevention and care alongside population ageing. The rise in corpus uteri cancer represents an emerging public health concern potentially associated with increasing metabolic risk factors, highlighting the need for targeted prevention strategies.
Indexed as
Identifiers
42234293What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.